Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Wet Macular Degeneration”

Showing 4 of 0 results

Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Large-scale testing (Phase 3)Study completedNCT00041483
What this trial is testing

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

Who this might be right for
Macular Degeneration
Alcon Research 530
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Early research (Phase 1)Study completedNCT06969001
What this trial is testing

Clinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye Drops

Who this might be right for
Wet Age Related Macular Degeneration
SCAI Therapeutics 48

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation